WITHDRWAN: Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: a double-blinded, randomized, placebo controlled study.

Bernstein AM, Roizen MF, Martinez L

Open source

DOI
10.1016/j.jacl.2014.08.001
Published
2014 Nov-Dec
Container
Journal of clinical lipidology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacl.2014.08.001,
  title = {WITHDRWAN: Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: a double-blinded, randomized, placebo controlled study.},
  author = {Bernstein AM and Roizen MF and Martinez L},
  year = {2014},
  journal = {Journal of clinical lipidology},
  doi = {10.1016/j.jacl.2014.08.001},
  url = {https://doi.org/10.1016/j.jacl.2014.08.001}
}

RIS

TY  - JOUR
TI  - WITHDRWAN: Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: a double-blinded, randomized, placebo controlled study.
AU  - Bernstein AM
AU  - Roizen MF
AU  - Martinez L
PY  - 2014
JO  - Journal of clinical lipidology
DO  - 10.1016/j.jacl.2014.08.001
UR  - https://doi.org/10.1016/j.jacl.2014.08.001
ER  - 

APA

AM, B., MF, R., & L, M. (2014). WITHDRWAN: Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: a double-blinded, randomized, placebo controlled study.. Journal of clinical lipidology. https://doi.org/10.1016/j.jacl.2014.08.001

Source records